Dr. Richard M. Eglen is a plenary keynote speaker and session chair at ELRIG’s first meeting of 2017, Research & Innovation, which will take place at Homerton College, University of Cambridge on 29th and 30th March.
As vice president and general manager of Corning Life Sciences, Richard is responsible for setting and executing the strategic direction for the Division’s growth within Corning Incorporated.
Eglen joined Corning in 2011 with over 35 years’ experience in the Life Science industry, including several executive management positions in the pharmaceutical, diagnostic, and biotech industries. Previous appointments include vice president of the Centre for Biological Research at Roche, executive vice president for Research and Development at DiscoverX Corp. and, most recently, president of Bio-discovery, PerkinElmer.
Richard has worked extensively in the cellular science area, focusing on GPCR, kinase, and ion channels, as well as in assay and instrument technology development for high-throughput screening, imaging, and biomarker detection.
He has authored more than 320 publications, book chapters, and patents, and serves on numerous industry, academic advisory, and journal editorial boards. Eglen received his Bachelor of Science degree in Special Honours Physiology from Sheffield University, UK and a Ph.D. in Molecular Pharmacology from Trent University, UK.
For further information or to register for Research & Innovation 2017, visit the event web page on the ELRIG website by clicking here.